journal
Journals Current Medical Research and O...

Current Medical Research and Opinion

https://read.qxmd.com/read/39250177/user-experience-with-hiv-molecular-epidemiology-in-research-surveillance-and-cluster-detection-and-response-a-needs-assessment
#1
JOURNAL ARTICLE
Anne L R Schuster, Ashley Folta, Juli Bollinger, Gail Geller, Sanjay R Mehta, Susan J Little, Travis Sanchez, Jeremy Sugarman, John F P Bridges
OBJECTIVE: HIV molecular epidemiology (HIV ME) is a tool that aims to improve HIV research, surveillance, and cluster detection and response. HIV ME is a core pillar of the U.S. initiative to End the HIV Epidemic but faces some challenges and criticisms from stakeholders. We sought to assess user experience to identify the current needs for HIV ME. METHODS: Users of HIV ME, including researchers and public health practitioners, were engaged via a structured survey...
September 9, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39235266/efficacy-and-safety-of-insulin-degludec-biosimilar-b01411-versus-originator-insulin-degludec-in-chinese-patients-with-type-2-diabetes-inadequately-controlled-on-oral-antidiabetic-drugs-a-multicenter-randomized-open-label-phase-3-study
#2
JOURNAL ARTICLE
Linong Ji, Leili Gao, Zhifeng Cheng, Guoqing Ma, Shu Li, Haifang Wang, Jie Liu, Yibing Lu, Meiying Liu, Jianlin Geng, Yunming Gao, Hongwei Ling, Wenli Sun, Chengwei Song, Jingfang Sun
OBJECTIVE: To compare the efficacy and safety of insulin degludec biosimilar B01411 (HS-IDeg) with originator insulin degludec-Tresiba (NN-IDeg) in Chinese patients with type 2 diabetes mellitus (T2DM) who were inadequately controlled on oral antidiabetic drugs (OADs) for at least 3 months. METHODS: This multicenter, randomized, open-label, parallel-group, active-controlled, phase 3 study enrolled 362 participants with T2DM. Participants were stratified according to whether the insulin secretagogue (sulfonylurea or glinide) had been used before the screening and then randomized 1:1 to receive once-daily subcutaneous injections of HS-IDeg (n = 180) or NN-IDeg (n = 182) for 18 weeks...
September 5, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39235073/a-systematic-review-and-meta-analysis-evaluating-the-association-of-high-sensitivity-troponin-levels-with-outcomes-in-patients-with-stable-coronary-artery-disease
#3
JOURNAL ARTICLE
Rupak Desai, Nanush Damarlapally, Srijan Bareja, Vaishnavi Arote, Srivatsa Surya Vasudevan, Kamya Mehta, Mariam Ashfaque, Yadeshini Jayachandran, Shrikanth Sampath, Alaknanda Behera, Archit Srivatsava, Shariq Nawab, Sriharsha Dadana
BACKGROUND: High-sensitivity cardiac troponins (Hs-cTns) are reliable indicators of myocardial injury, but their relationship with cardiovascular outcomes remains less understood. This study explored the association between adverse cardiac events and Hs-cTnT levels exceeding 14ng/L in patients with stable CAD. METHODS: Thirteen pertinent studies were identified using specific keywords from a pool of 208 articles retrieved from PubMed, Scopus, and Google Scholar, spanning 2013 to 2023...
September 5, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39231039/icu-outcomes-following-a-central-line-associated-blood-stream-infections-clabsi-reduction-quality-improvement-project
#4
JOURNAL ARTICLE
Ronald Harris, Nitin L Mehdiratta, Morgan A Rosser, Anand M Chowdhury, Becky A Smith, Karthik Raghunathan, Vijay Krishnamoorthy
BACKGROUND: Central Line Associated Blood Stream Infections (CLABSI) are significant complications for hospitalized patients. Several different approaches have been used to reduce CLABSI. OBJECTIVE: This study aimed to (1) describe a systematic approach used to analyze and reduce CLABSI rates in a surgical ICU (SICU) at a quaternary care medical facility (CLABSI reduction bundle) and (2) examine the association of the bundle on CLABSI rates in the SICU, compared to six unexposed health system ICUs...
September 4, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39226081/matching-adjusted-indirect-comparison-of-talquetamab-vs-selinexor-dexamethasone-and-vs-belantamab-mafodotin-in-patients-with-relapsed-refractory-multiple-myeloma
#5
JOURNAL ARTICLE
Donna Reece, Joris Diels, Suzy Van Sanden, Lixia Pei, Eric Ammann, Christoph Heuck, Colleen Kane, Anil Londhe, Steve Peterson, Ajai Chari
OBJECTIVE: Talquetamab is the first GPRC5D-targeting bispecific antibody approved for the treatment of triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM). This matching-adjusted indirect comparison (MAIC) study was conducted to compare the effectiveness of talquetamab vs selinexor-dexamethasone (sel-dex) and vs belantamab mafodotin (belamaf) in patients with TCE RRMM. METHODS: An unanchored MAIC was performed using individual patient-level data from patients treated with subcutaneous talquetamab 0...
September 3, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39225341/the-journey-to-ldl-c-goal-in-the-era-of-combination-lipid-lowering-therapy-and-why-it-matters-for-ascvd-patients-a-uk-perspective
#6
JOURNAL ARTICLE
Mohamed Elnaggar, Ashley M Miller, Arunesh Sil, Adie Viljoen
OBJECTIVE: We aim to explore the concept of distance and journey to goal, and consideration of these 2 elements a priori when choosing LLT. METHODS: Modelling of expected % LDL-C reductions was carried out on a range of hypothetical patients' baseline LDL-C values prior to any LLT being commenced. Therapies were then added in a stepwise manner based on the pathway demonstrated in current national guidance and compared with goal achievement on a novel LLT optimisation pathway implemented in Morecambe Bay NHS Trust...
September 3, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39212602/perception-and-knowledge-of-general-practitioners-on-copd-management-according-to-the-gold23-document-and-reimbursement-criteria-for-drugs-prescription-an-e-delphi-study
#7
JOURNAL ARTICLE
Ettore Marconi, Francesco Paolo Lombardo, Claudio Micheletto, Marzio Uberti, Fabiano Di Marco, Alessandro Rossi, Claudio Cricelli, Francesco Lapi
BACKGROUND: COPD management and therapy have been periodically revised to support a more patient-specific approach. Several concerns remain in primary care, such as the proper choice of initial treatment, medication adherence, and missing values for spirometry investigations. These concerns may be exacerbated by inconsistencies between the GOLD23 report and reimbursement criteria, as per the Italian NOTA99, especially for what concerns the assessment of disease severity and related treatment choice...
August 30, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39210892/the-role-of-systemic-inflammatory-indices-in-predicting-atrial-fibrillation-and-its-complications-a-narrative-review
#8
REVIEW
Atefeh Ghareghani, Shahin Abbaszadeh, Mohammad Ali Takhshid
Atrial fibrillation (AF) is associated with increased morbidity and mortality. Inflammation and oxidative stress play critical roles in AF occurrence and its complications. Therefore, evaluating the circulating levels of inflammatory and oxidative stress biomarkers and their possible applications in AF diagnosis and management have been the focus of many efforts. The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) and neutrophil-to-lymphocyte ratio (NLR) are two non-invasive, available, and established markers that serve as indicators of inflammation and oxidative stress...
August 30, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39207314/author-language-and-communication-preferences-and-familiarity-with-global-publication-guidelines-for-english-language-industry-sponsored-publications-in-asia-pacific-insights-from-a-cross-sectional-survey
#9
JOURNAL ARTICLE
Alice Carruthers, Henry Chung, Rebecca Crawford, Joyce H Y Lee, Jonathan Lee
OBJECTIVE: To understand current practices and challenges for collecting author feedback for English-language, industry-sponsored publications in Asia-Pacific (APAC), and the implications for adherence to international publication guidelines. METHODS: A cross-sectional, internet-based survey of industry ('internal') authors (17 questions) and publication professionals (18 questions) supporting publications in APAC, conducted between November 18 and December 4, 2022...
August 29, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39189143/congenital-cytomegalovirus-diagnosis-healthcare-claims-data-of-linked-pregnant-people-infant-pairs-united-states-2018-2023
#10
JOURNAL ARTICLE
Oscar Rincón-Guevara, Jessica Leung, David E Sugerman, Tatiana M Lanzieri
OBJECTIVE: To describe maternal demographics and compare clinical characteristics of infants with congenital cytomegalovirus (cCMV) identified through diagnostic codes and laboratory data in the United States during 2018-2023. METHODS: We used a CDC-licensed subset of HealthVerity data, which contained linked pregnant people-infant claims data from publicly and privately insured individuals during 2018-2023 (2023 Quarter 3 HealthVerity Maternal Outcomes Masterset data)...
August 27, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39177339/the-role-of-psilocybin-in-depressive-disorders
#11
REVIEW
Jadwiga Najib
Depression is a serious psychiatric disorder with a high incidence of morbidity and mortality and psilocybin with psychotherapy has emerged as a promising potential in the treatment of depressive disorders. A review of psilocybin use in patients with depressive disorders is presented.A search was conducted investigating the use of psilocybin in patients with depressive disorders and treatment resistant depression via PubMed/MEDLINE, EMBASE, and Google Scholar in October 2023; all publication types were permitted and limited for English-language...
August 28, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39177290/real-world-experience-with-clinical-management-of-talquetamab-in-relapsed-refractory-multiple-myeloma-a-qualitative-study-of-us-healthcare-providers
#12
JOURNAL ARTICLE
Carolina Schinke, Binod Dhakal, Sandra Mazzoni, Samantha Shenoy, Sara A Scott, Tiffany Richards, Hoa H Le, Amalia DeBrosse, Peter Okorozo, Rachel McDowell, Saurabh Patel, Jonathan Bunn, Kelly Hawks, Xinke Zhang, Cesar Rodriguez
OBJECTIVE: Talquetamab is the first-in-class GPRC5DxCD3 bispecific antibody for relapsed/refractory multiple myeloma. Given limited real-world data, this study was conducted with US healthcare providers (HCPs) to understand real-world talquetamab dosing and symptom management. METHODS: In February/March 2024, individual in-depth interviews (IDIs; n  = 10) were conducted with HCPs administering talquetamab in real-world settings. A subsequent expert panel ( n  = 6) further discussed current practices...
August 23, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39175422/understanding-the-impact-of-slowing-disease-progression-for-individuals-with-biomarker-confirmed-early-symptomatic-alzheimer-s-disease
#13
REVIEW
Urvi Desai, Dumingu Aparna Gomes, Julie Chandler, Wenyu Ye, Michael Daly, Noam Kirson, Ellen B Dennehy
Recent advances in development of amyloid-targeting therapies support the potential to slow the rate of progression of Alzheimer's disease. We conducted a narrative review of published evidence identified through a targeted search of the MEDLINE and EMBASE databases (2020-2023), recent presentations at disease-specific conferences, and data updates from cohort studies in Alzheimer's disease to describe the trajectory of progression of Alzheimer's disease. Our findings enable interpretation of clinical trial results and the value associated with slowing disease progression across outcomes of relevance to patients, care partners, clinicians, researchers and policymakers...
August 23, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39171487/seizure-burden-and-healthcare-resource-utilization-among-people-living-with-drug-resistant-focal-epilepsy-in-the-united-states
#14
JOURNAL ARTICLE
Jianbin Mao, Yan Song, Mu Cheng, Churong Xu, Andra Boca, Ann Dandurand, Koji Takahashi
OBJECTIVE: This study investigated clinical characteristics, burden of uncontrolled seizures, and seizure-related healthcare resource utilization (HRU) among individuals living with drug-resistant focal epilepsy (FE) in the United States (US). METHODS: Medical charts of adults with drug-resistant FE who initiated third-line (3L) anti-seizure medication were extracted from clinical practices in the US (1/1/2013-1/31/2020). The index date, defined as the date of 3L initiation, was used to indicate the emergence of drug resistance...
August 22, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39166959/efficacy-and-safety-of-interventions-for-metastatic-castration-resistant-prostate-cancer-mcrpc-patients-progressing-on-androgen-receptor-axis-targeted-arat-therapy-a-systematic-literature-review
#15
REVIEW
Kevin Yan, Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy, Sharon Kotum, Eric Druyts
BACKGROUND: To review the literature to outline findings from clinical trials assessing interventions for metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on androgen receptor-axis-targeted (ARAT) therapies. METHODS: A systematic literature review was performed to identify trials that assessed the efficacy and safety of interventions used in patients that progressed on prior ARAT therapies. A literature search was conducted using the OVID platform that searched the EMBASE, MEDLINE, and CENTRAL bibliographic databases...
August 21, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39148452/risk-of-coronal-imbalance-after-posterior-surgery-for-adolescent-idiopathic-scoliosis-of-type-lenke-5c
#16
JOURNAL ARTICLE
Huanhuan Qiao, Kang Yan, Bo Liao
PURPOSE: To investigate the incidence, risk factors, and clinical impact of persistent coronal imbalance (PCI) in Lenke5C adolescent idiopathic scoliosis (AIS) undergoing posterior spinal fusion (PSF). METHODS: We analyzed the medical records of 112 Lenke5C AIS patients. They were grouped into PCI (+) group and PCI (-) group according to the occurrence of PCI at 2 years after surgery. Coronal and sagittal parameters were measured and compared between both groups preoperatively, immediately postoperatively, and 2 years postoperatively...
August 16, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39129504/comparative-efficacy-of-ciltacabtagene-autoleucel-versus-idecabtagene-vicleucel-in-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma-previously-treated-with-2-4-prior-lines-of-therapy-a-matching-adjusted-indirect-comparison
#17
JOURNAL ARTICLE
Noffar Bar, Joris Diels, Suzy van Sanden, João Mendes, Teresa Hernando, Heather Burnett, Patricia Cost, Jordan M Schecter, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J Harrison, Nieves Lopez-Muñoz
OBJECTIVE: To estimate the comparative efficacy of ciltacabtagene autoleucel (cilta-cel) versus idecabtagene vicleucel (ide-cel) in patients with relapsed/refractory multiple myeloma (RRMM) treated with 2-4 prior lines of therapy. METHODS: Matching adjusted indirect comparison (MAICs) were performed using individual patient-level data (IPD) for cilta-cel from CARTITUDE-1 and CARTITUDE-4 and published aggregated data for ide-cel from KarMMa-3. Cilta-cel patients who met inclusion criteria from KarMMa-3 were selected, and outcomes were compared against data for ide-cel using simulated IPD derived from aggregate-level data from KarMMa-3...
August 12, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39115296/exploring-the-interplay-of-abstinence-self-efficacy-locus-of-control-and-perceived-social-support-in-substance-use-disorder-recovery
#18
JOURNAL ARTICLE
Priti Rekha Das, Rita Rani Talukdar, Chandan Jyoti Kumar
INTRODUCTION: Substance use disorder (SUD) poses a significant public health challenge globally, with substantial impacts on physical and social well-being. This study investigates the interplay between abstinence self-efficacy (ASE), locus of control (LOC), perceived social support (PSS), and various socio-demographic and psychosocial factors among individuals undergoing SUD rehabilitation. METHODS: Researchers obtained permission from drug rehabilitation centers in Assam, India, and conducted orientation programs for prospective participants...
August 8, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39115280/beyond-breast-cancer-role-of-selective-estrogen-receptor-modulators-in-reducing-systemic-malignancies-evidence-from-population-based-data
#19
JOURNAL ARTICLE
Jeongmin Lee, Jinyoung Kim, Chaiho Jeong, Ki-Hyun Baek, Jeonghoon Ha
BACKGROUND: Raloxifene and bazedoxifene are selective estrogen receptor modulators (SERMs) used to prevent and treat osteoporosis in postmenopausal women. Raloxifene is also known for its preventive effect against invasive breast cancer; however, its effect on other cancer types is unclear. This study investigated the incidence of various cancers in osteoporosis patients receiving SERM therapy to determine its association with the risk of developing specific cancer types. METHODS: This retrospective cohort study examined the association between SERM use and the incidence of cervical, endometrial, ovarian, and colorectal cancers in postmenopausal women using data from the Korean National Health Insurance Service...
August 8, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/39110846/safety-and-effectiveness-of-vortioxetine-in-patients-with-major-depressive-disorder-in-a-real-life-clinical-setting-in-india-results-from-an-interventional-flexible-dose-study
#20
JOURNAL ARTICLE
Michael Adair, Rohini Bose, Simon Nitschky Schmidt
OBJECTIVE: Vortioxetine has demonstrated safety and efficacy in improving symptoms of major depressive disorder (MDD), including overall functioning in real-world settings. This is the first study in a real-life clinical setting in India to evaluate effectiveness and safety of vortioxetine in patients with MDD. METHODS: This interventional, open-label study consisted of a 12-week treatment period with flexible doses of vortioxetine (5-20 mg/day) in adult patients (aged 18-65 years) with a confirmed MDD diagnosis...
August 7, 2024: Current Medical Research and Opinion
journal
journal
22988
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.